132 related articles for article (PubMed ID: 16267191)
1. Intermittent intramuscular clodronate therapy: a valuable option for older osteoporotic women.
Dominguez LJ; Galioto A; Ferlisi A; Alessi MA; Belvedere M; Putignano E; Costanza G; Bevilacqua M; Barbagallo M
Age Ageing; 2005 Nov; 34(6):633-6. PubMed ID: 16267191
[No Abstract] [Full Text] [Related]
2. "Twice-a-month" clodronate 200 mg IM: a new dosing regimen and improved therapy adherence in the treatment of postmenopausal osteoporosis.
Muratore M; Quarta L; Calcagnile F; Quarta E
Adv Ther; 2010 May; 27(5):314-20. PubMed ID: 20526703
[TBL] [Abstract][Full Text] [Related]
3. Effect of intramuscular clodronate on bone mass and metabolism in osteoporotic women.
Gnudi S; Lisi L; Fini M; Malavolta N
Int J Tissue React; 2001; 23(1):33-7. PubMed ID: 11392061
[TBL] [Abstract][Full Text] [Related]
4. A 4-year treatment with clodronate plus calcium and vitamin D supplements does not improve bone mass in primary biliary cirrhosis.
Floreani A; Carderi I; Ferrara F; Rizzotto ER; Luisetto G; Camozzi V; Baldo V
Dig Liver Dis; 2007 Jun; 39(6):544-8. PubMed ID: 17416215
[TBL] [Abstract][Full Text] [Related]
5. Strontium: new drug. Postmenopausal osteoporosis: too many unknowns.
Prescrire Int; 2005 Dec; 14(80):207-11. PubMed ID: 16397977
[TBL] [Abstract][Full Text] [Related]
6. Clodronic acid in the treatment of postmenopausal osteoporosis.
Tanakol R; Yarman S; Bayraktaroglu T; Boztepe H; Alagöl F
Clin Drug Investig; 2007; 27(6):419-33. PubMed ID: 17506592
[TBL] [Abstract][Full Text] [Related]
7. Effects of two administration schemes of intramuscular clodronic acid on bone mineral density: a randomized, open-label, parallel-group study.
Frediani B
Clin Drug Investig; 2011; 31(1):43-50. PubMed ID: 20932069
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of teriparatide in elderly women with established osteoporosis: bone anabolic therapy from a geriatric perspective.
Boonen S; Marin F; Mellstrom D; Xie L; Desaiah D; Krege JH; Rosen CJ
J Am Geriatr Soc; 2006 May; 54(5):782-9. PubMed ID: 16696744
[TBL] [Abstract][Full Text] [Related]
9. Intra-articular clodronate for the treatment of knee osteoarthritis: dose ranging study vs hyaluronic acid.
Rossini M; Viapiana O; Ramonda R; Bianchi G; Olivieri I; Lapadula G; Adami S
Rheumatology (Oxford); 2009 Jul; 48(7):773-8. PubMed ID: 19406908
[TBL] [Abstract][Full Text] [Related]
10. Treatment with alendronate plus calcium, alendronate alone, or calcium alone for postmenopausal low bone mineral density.
Bonnick S; Broy S; Kaiser F; Teutsch C; Rosenberg E; DeLucca P; Melton M
Curr Med Res Opin; 2007 Jun; 23(6):1341-9. PubMed ID: 17594775
[TBL] [Abstract][Full Text] [Related]
11. Evidence that treatment with risedronate in women with postmenopausal osteoporosis affects bone mineralization and bone volume.
Fratzl P; Roschger P; Fratzl-Zelman N; Paschalis EP; Phipps R; Klaushofer K
Calcif Tissue Int; 2007 Aug; 81(2):73-80. PubMed ID: 17612779
[TBL] [Abstract][Full Text] [Related]
12. No difference between strontium ranelate (SR) and calcium/vitamin D on bone turnover markers in women with established osteoporosis previously treated with teriparatide: a randomized controlled trial.
Anastasilakis AD; Goulis DG; Polyzos SA; Gerou S; Ballaouri I; Efstathiadou Z; Kita M; Avramidis A
Clin Endocrinol (Oxf); 2009 Apr; 70(4):522-6. PubMed ID: 18625000
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of teriparatide in increasing bone mineral density in postmenopausal women with osteoporosis--an Indian experience.
Sethi BK; Chadha M; Modi KD; Kumar KM; Mehrotra R; Sriram U
J Assoc Physicians India; 2008 Jun; 56():418-24. PubMed ID: 18822620
[TBL] [Abstract][Full Text] [Related]
14. Continuous and cyclical clodronate therapies and bone density in postmenopausal bone loss.
Giannini S; D'Angelo A; Sartori L; Passeri G; Dalle Carbonare L; Crepaldi G
Obstet Gynecol; 1996 Sep; 88(3):431-6. PubMed ID: 8752254
[TBL] [Abstract][Full Text] [Related]
15. The effects of strontium ranelate in Asian women with postmenopausal osteoporosis.
Hwang JS; Chen JF; Yang TS; Wu DJ; Tsai KS; Ho C; Wu CH; Su SL; Wang CJ; Tu ST
Calcif Tissue Int; 2008 Nov; 83(5):308-14. PubMed ID: 18843436
[TBL] [Abstract][Full Text] [Related]
16. Once-yearly administered intravenous zoledronic acid for postmenopausal osteoporosis.
Woodis CB
Ann Pharmacother; 2008 Jul; 42(7):1085-9. PubMed ID: 18505912
[TBL] [Abstract][Full Text] [Related]
17. Improved efficacy of intramuscular weekly administration of clodronate 200 mg (100 mg twice weekly) compared with 100 mg (once weekly) for increasing bone mineral density in postmenopausal osteoporosis.
Frediani B; Bertoldi I; Pierguidi S; Nicosia A; Picerno V; Filippou G; Cantarini L; Galeazzi M
Clin Drug Investig; 2013 Mar; 33(3):193-8. PubMed ID: 23456672
[TBL] [Abstract][Full Text] [Related]
18. [Basic aspects of osteoporosis therapy with active vitamin D metabolites].
Schacht E
Med Klin (Munich); 1996 Feb; 91 Suppl 1():34-7. PubMed ID: 8839112
[No Abstract] [Full Text] [Related]
19. [The role of vitamin D in the treatment of osteoporosis in the elderly].
Pfeifer M; Minne HW
Med Klin (Munich); 2006 Jun; 101 Suppl 1():15-9. PubMed ID: 16826364
[TBL] [Abstract][Full Text] [Related]
20. [New bone density conservation agents for osteoporosis under research and development: PTH (1-34)].
Endo I; Matsumoto T
Nihon Rinsho; 2007 Nov; 65 Suppl 9():443-6. PubMed ID: 18161146
[No Abstract] [Full Text] [Related]
[Next] [New Search]
